Search
T-62
go.drugbank.com/drugs/DB12919InvestigationalT-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Synonyms: T-62Quercetin-3'-O-phosphate
go.drugbank.com/drugs/DB12937InvestigationalQuercetin-3'-O-phosphate has been used in trials studying the treatment of Insulin Resistance and Impaired Glucose Tolerance.
Troxerutin
go.drugbank.com/drugs/DB13124InvestigationalTroxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
Mixtures: LACORYL® -T GEL, LACORYL® -T GELDaporinad
go.drugbank.com/drugs/DB12731InvestigationalDaporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.
Radium Ra-223
go.drugbank.com/drugs/DB12813InvestigationalRadium 223 is under investigation in clinical trial NCT02463799 (Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC).
IPH 1101
go.drugbank.com/drugs/DB05754ExperimentalIPH 1101 is the most advanced drug candidate of the γδ T cell platform … IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset.
FAV-201
go.drugbank.com/drugs/DB06130ExperimentalFAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.
TNP-470
go.drugbank.com/drugs/DB08633InvestigationalO-(chloroacetylcarbamoyl)fumagillol (TNP-470) has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, and Pancreatic Neoplasms.
Synonyms: O-(chloroacetylcarbamoyl)fumagillol, O-chloroacetylcarbamoylfumagillolRTL-1000
go.drugbank.com/drugs/DB17946InvestigationalRTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.
Synonyms: Recombinant t-cell receptor ligand rtl-1000, Rtl-1000 (recombinant t-cell receptor ligand)Satricabtagene autoleucel
go.drugbank.com/drugs/DB18288InvestigationalSatricabtagene autoleucel is an autologous CAR T-cell product candidate against protein Claudin18.2 (CLDN18.2).